Trials / Not Yet Recruiting
Not Yet RecruitingNCT06414837
Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
Study on Efficacy and Safety of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 434 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy, and safety of HR091506 tablets for treatment of gout with hyperuricemia in adults, and to compare the results with febuxostat tablets in the same doses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HR091506 tablets + placebo of febuxostat tablets | HR091506 tablets 20mg/ 40mg/ 60mg/80mg qd + placebo of febuxostat tablets 20mg/ 40mg/ 60mg/80mg qd, from Week 1 to 36. |
| DRUG | febuxostat tablets + placebo of HR091506 tablets | febuxostat tablets 20mg/ 40mg/ 60mg/80mg qd + placebo of HR091506 tablets 20mg/ 40mg/ 60mg/80mg qd . from Week 1 to 36. |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2024-05-16
- Last updated
- 2024-05-16
Source: ClinicalTrials.gov record NCT06414837. Inclusion in this directory is not an endorsement.